Key result
Electro-thermal modeling shows RF ablation lesion orderings persist across return locations, supporting screening use.
Why the study?
Radiofrequency ablation comparisons are confounded by energy, latency, perfusion, assumptions, and controller action, necessitating a bounded electro-thermal model to compare protocols.
How do different power-time allocation protocols affect lesion formation and peak temperatures in a computational model of radiofrequency cardiac ablation?
How do different power-time allocation protocols affect lesion formation and peak temperatures in a computational model of radiofrequency cardiac ablation?
Computational modeling of radiofrequency ablation shows that equal-energy protocols yield different peak temperatures and that temperature limitation actively modifies power delivery.
Supports model-based screening of ablation protocols; leaves open clinical translation pending in vivo validation.
Radiofrequency ablation comparisons are confounded by energy, latency, perfusion, assumptions, and controller action. An assumption-bounded two-dimensional electro-thermal model compared 30 W/30 s, 50 W/10 s, fixed 90 W/4 s, and temperature-limited 90 W/4 s protocols. A 30 s post-pulse endpoint passed 12/12 cases. Equal-energy peak temperatures differed. In the 4 mm-buffer grid, the limiter reduced power in 29/60 cells. Peak-temperature and protocol-associated perfusion-effect orderings persisted across return-location tests, whereas the presence of the Arrhenius damage contour Ω ≥ 1 and controller intervention were return-sensitive. This supports screening, not absolute or patient-level prediction.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied Radiofrequency cardiac ablation. Radiofrequency ablation protocols was evaluated on Lesion formation characteristics (peak temperatures, perfusion-effect orderings, Arrhenius damage contour). An electro-thermal model of radiofrequency ablation protocols demonstrated that peak-temperature and perfusion-effect orderings persisted across return-location tests, supporting screening use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: